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Nemaline myopathy (NM) is an uncommon congenital muscle disease with an
incidence of 0.02 per 1,000 live births.1 According to the degree of muscle
weakness, severity, and age at onset, five forms have been clinically defined by
the European Neuromuscular Center (ENMC) International Consortium on NM.2-4
Five clinical subtypes (severe, intermediate, typical congenital, mild childhood,
and adult onset) reflect the clinical heterogeneity of this disease. The most common
classical form is characterized by onset in early infancy or childhood with
hypotonia or general weakness predominantly affecting facial, axial, and proximal
limb muscles. The course is typically static or only slowly progressive, and the
degree of cardiorespiratory involvement is the main prognostic factor.5 Cases are
often sporadic, but some exhibit either autosomal recessive or dominant patterns
of inheritance. The characteristic pathognomic feature is the presence of intrasar-
colemmal rods, which are seen on light microscopy visualized with modified
Gomori trichrome stains, and electron dense nemaline bodies of Z-band origin on
ultrastructural examination.6 Usually, the rods are present in the type 1 fibers, and
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INTRODUCTION
the proportion of fibers that contain rods can also vary
among individuals.2 Another important histopathologic
feature frequently observed in NM is type 1 predominance.
Over the past few years, several cases have been reported
in Korea but little attention has been given to the clinico-
pathological features of NM. The purpose of this study is
to investigate the clinical diversity and pathological features
of Korean patients with NM.
Patients
A total of 8 patients were included in this retrospective
investigation and diagnosed with NM at our hospital
between 1993 and 2006. Diagnosis was based on clinical
examination, course of the disease, family history, serum
creatine kinase levels, electromyography, and muscle
biopsy. Study protocol data collected from each patient in-
cluded: 1) detailed personal history (age at onset, initial
symptom or sign, developmental delay, and clinical course),
2) clinical presentations (distribution of muscle weakness
and atrophy, progression pattern, cardiac or respiratory
involvement, dysphagia, and mental retardation), 3) dysmor-
phic features (pseudohypertrophy, high arched palate and
foot, elongated face, and spinal deformity), 4) laboratory
data (serum creatine kinase, electromyography and nerve
conduction velocity, muscle biopsy), and 5) muscle power
(manual muscle testing).
Histopathologic study 
All patients underwent an open biopsy of the deltoids or
biceps under local or general anesthesia. Muscle samples
were frozen in liquid nitrogen immediately after removal
and stored at -70˚C and remained so until time of use. Trans-
verse serial frozen muscle sections were stained with hema-
toxylin and eosin (H&E), modified Gomori trichrome,
adenosine triphosphatase (ATPase, at pH 9.4, 4.6, and 4.3),
and nicotinamide adenine dinucleotide (NADH)-tetrazolium
reductase (TR) stains. 
Clinical features
Details of each patient are shown in Table 1. Six male and
two female patients were investigated. The age at the time
of the muscle biopsy varied from 14 to 43 years. Two
patients were familial cases and the others were sporadic. 
Five patients were infants or children when lower limb
weakness began without delayed motor milestone. Two
patients, however, had congenital mild hypotonia and
weakness during the neonatal period. One (patient No. 2) of
two patients with neonatal hypotonia and weakness started
to walk unassisted at 36 months of the age and the other
(patient No. 3) began at 7 years. In only one patient, dyspnea
was the first symptom that began during adulthood without
preceding symptoms, and acute respiratory insufficiency
developed within the course of two months. Mental develop-
ment was normal in all patients. These 5, 2, and 1 patients
were classified as childhood onset, typical congenital, and
adult onset types, respectively, according to the ENMC
International Consortium on NM.
The lower extremities were most often initially affected
by limb weakness and distribution of muscle weakness
was remarkably in proximal parts. However, one patient
was weaker in distal limbs than proximal and both were
equal on manual muscle testing. Weakness in the neck
flexor and facial muscles was observed in two typical
congenital patients and the one adult onset patient. 
High arched palates (n = 6), high arched feet (n = 5), and
elongated faces (n = 4) were observed as dysmorphic
features. Most patients exhibited reduced tendon reflexes,
and scoliosis was observed in one patient. Other ortho-
pedic abnormalities such as arthrogryposis were not found.
Cardiomyopathy and opthalmoplegia were not exhibited.
The clinical course was static or slowly progressive except
for the adult onset patient. 
A nerve conduction study showed normal results in most
of the patients. A needle electromyography study showed a
combination of small brief motor unit action potentials
with reduced recruitment in six patients as well as dener-
vating potential in two of these. Two patients showed
normal findings. The mean serum creatine kinase level
was 107 IU/L (range 25-369 IU/L). 
Pathological findings 
Muscle biopsies of all 8 patients showed similar changes.
Microscopic examination revealed normal fascicular archi-
tecture with no endomysial or perimysial fibrosis and
adipose tissue infiltration (Fig. 1A). There was a mild
variation in fiber size without central localization nuclei.
Modified Gomori trichrome stains showed characteristic
purple-colored rods in the cytoplasm and subsarcolemmal
region, which were more prominent in type 1 fibers (Fig.
1B and C). Type 1 fiber predominance was observed in all
patients, which was accompanied by selective type 1 fiber
atrophy in seven patients (Fig. 1D and E). Nemaline rods
were confined to type 1 fibers in five of the eight biopsies
in which fiber type distribution of rods was determined
(Fig. 1F and G). Rods were never confined to type 2 fibers.
Type 2 fiber predominance was not seen. Intranuclear rods
were not identified in any case. There was no evidence of
central cores, minicores, central nuclei, reducing bodies, or
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target fibers in any of the eight patients. In the two cases
where ultrastructural studies were done, typical nemaline
rods and disorganized myofibrillar apparatus were detected
(Fig. 1H and I). 
NM was originally described independently by Shy, et al.8
and Conen, et al.7 in 1963 as a non-progressive myopathy
with a distinctive morphologic abnormality designated as
myogranules or rods of thread-like fibrous material. NM
shares common clinical expressions such as proximal limb
weakness, slow progression, and characteristic dysmorphic
features shown with other congenital myopathies. NM can
be categorized into five subtypes on the basis of its clinical
features as follows: by the pattern of weakness, age at onset,
or respiratory involvement. Thus, clinical presentations of
NM are heterogeneous. The typical form of NM is usually
autosomal recessive and it presents with congenital or
infantile hypotonia, weakness, and often feeding difficulties
are present during the neonatal period or first year of life.9
In cases with profound weakness and hypotonia during the
neonatal period, strength often improves with age, leading
to delayed attainment of gross motor skills but most of
these patients are able to lead an independent life. Severe
and intermediate congenital forms may have severe weak-
ness and hypotonia with a rapidly progressive course
leading to respiratory failure.10 Of mild childhood forms,
the mildest end of the spectrum are patients with similar
clinical findings to the typical forms, but with a childhood
onset of symptoms.11 At later ages, these mild cases can be
indistinguishable from typical cases with the age at onset
as the only differentiating factor.11 There is also a progres-
sive adult onset form that represents a separate, quite heter-
ogeneous group of patients in terms of clinical presentation
with an onset in the third to sixth decade. The adult onset
form is characterized by rather selective acute or subacute
respiratory dysfunction without preceding symptoms with
sporadic or autosomal recessive inheritance.12
Our study also showed clinical diversity of NM. Two
patients had the typical congenital type of NM which
exhibited neonatal hypotonia and delayed motor milestones,
and five patients had the childhood onset type which
DISCUSSION
Fig. 1. Pathologic findings of nemaline myopathy. (A and B) Hematoxylin and eosin staining (×50, ×100) reveals mild to moderate fiber size variation.
Nemaline rods are not seen. (C and D) Numerous subsarcolemmal and cytoplasmic rods are apparent on a modified Gomori-trichrome stain (×100,
×200). (E) ATPase stain at pH 4.3 (×100) illustrates marked type 1 fiber predominance and hypotrophy. (F and G) NADH-TR stain (×200) shows
selective type 1 fiber atrophy and modified Gomori-trichrome stain (×400) demonstrates selective rod formation in hypotrophic type 1 fibers. (H and I)
Electron micrograph shows nemaline rods in cytoplasm and disorganized sarcomeric architecture with focal myofibrillar disarray.
exhibited mild proximal lower extremity weakness as a
first symptom. One patient had the adult onset type which
showed acute respiratory failure. There was a marked
overlap in clinical features between two typical and five
childhood type patients, but delayed motor milestones, facial
involvement, weakness of neck flexor muscle, and neonatal
hypotonia presented characteristically in typical congenital
patients.   
The seven typical congenital and childhood onset patients
exhibited static or slowly progressive clinical courses.
Although these subtypes have been described to be benign
clinical courses, there are a number of reports describing
patients with progressive muscle weakness and respiratory
failure.13 In NM, early mortality was not invariably due to
hypotonia or severe weakness but respiratory insufficiency.3
Therefore, baseline and follow-up pulmonary function
testing should be performed. 
In considering muscle pathology, analysis of the bio-
psies in our patients revealed that light microscopy is a
reliable method for the diagnosis of NM. Nemaline rods
are best demonstrated in frozen sections stained with the
modified trichrome technique, in which they appear as
reddish-purple granules measuring 2-7 µm in length. 
Our series also showed typical nemaline rods which
were more prominent in type 1 fibers. There were fiber size
variations and type 1 fiber predominance with selective
type 1 fiber atrophy. Nemaline rods were confined to type
1 fibers in more than half the number of our cases. On the
other hand we did not find rods confined to type 2 fibers. 
It is known that rods are found predominantly in type 1
fibers and affected fibers are often somewhat smaller than
normal.6 As in other congenital myopathies, the proportion
of fiber types deviated and type 1 predominance is fre-
quently observed.14 Studies performed on consecutive bio-
psies suggested a transformation of fiber type based on the
disappearance of type 2 fibers with age.13 Type 1 fiber pre-
dominance has been suggested as a primary cause of muscle
weakness in NM.15 Accordingly, a correlation exists bet-
ween the severity of clinical manifestations and alterations
in size and proportion of type 1 myofibers.6
The number of fibers containing rods and the number of
rods vary widely between patients and even between dif-
ferent muscles in individual cases.16 In the vast majority of
cases the rods are located exclusively in the cytoplasm, and
approximately 10% of the cases also show intranuclear
deposit.17 Although we could not find intranuclear rods in
our cases, prior reports suggested that the intranuclear rods
are associated with early presentation, more rapid progres-
sion, and a worse prognosis.10,16,18,19 However, rod location
within fibers or the subsarcolemmal region and the number
of rods do not correlate with the clinical severity or course of
illness.16,17
Genetically, disease-causing mutations have recently
been identified in five different genes, all of which encode
protein components of muscle thin filaments as follows: α-
tropomyosin (TPM3),20 nebulin (NEB),21 α-actin (ACTA1),22
β-tropomyosin (TPM2),23 and troponin T1 (TNNT1).24
Genes for these proteins have been localized and mutations
are fully characterized.11,25 Nebulin gene mutations are seen
most commonly in autosomal recessive cases and these
patients present as typical congenital NM.21 Some authors
demonstrated with linkage studies that nebulin gene muta-
tions at 2q21.2-q22 are responsible for 50% of the cases of
NM.21 TPM3 mutations have been described in rare cases
of dominant and recessive cases of NM, and rarely are
TPM2 and TNNT1 also implicated.20 ACTA1 mutations at
1q42 are reported to comprise 10% of the cases of NM,22
and are more common in severe cases of NM.1
There are also several cases in the literature of acquired
illnesses resulting in nemaline rod myopathy, and there
appears to be a strong association with HIV infection.26,27 In
the presence of HIV, the virus itself may trigger reactions
that cause de novo genetic mutations resulting in nemaline
formation.28 The reported HIV prevalence rate among
adults aged in 15-49 years in Korea is below 0.1%.29 
In conclusion, the eight Korean patients with NM shared
common clinical expressions such as proximal limb weak-
ness, reduced deep tendon reflex, and dysmorphic features.
This study, however, showed that clinical heterogeneity
ranged from typical congenital, mildly affected childhood
to adult onset forms with acute respiratory failure. The
characteristic pathological findings of nemaline rods and
type 1 predominance were in accordance with those of pre-
vious reports as well. To further characterization, genetic
analysis will be necessary.
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